CD73, What a Powerful Therapy Target in Tumor ImmuneOn October 27, 2020, Akeso, Inc. announced the completion of its first clinical trial in New Zealand for its innovative drug candidate CD73 monoclonal antibody named AK119, which was administered to healthy subjects. AK1... Detailed information
CD47, A New Target for Tumor ImmuneOn September 4th, 2020, IMAB and AbbVie jointly announced the establishment of a broad global partnership of the innovative CD47 monoclonal antibody lemzoprlimab (TJC4) independently developed by IMAB. IMAB will receive ... Detailed information
Hematopoietic Stem Cell Surface MarkerHematopoietic stem cells (HSC) are a type of adult stem cells with the characteristics of stem cells: self-renewal and differentiation potential.
Hematopoietic stem cells are a kind of pluripotent stem cells derive... Detailed information
Surface Markers of Mesenchymal Stem CellsMesenchymal stem cells (MSCs) are a kind of adult stem cells that exist in various tissues (such as bone marrow, umbilical cord blood and umbilical cord tissue, placental tissue, adipose tissue, etc.) and have multidirec... Detailed information
Identify Treg Cells. You Can Do This.The immune system can accurately identify "self" and "non-self", make the body produce protective immune response and realize the monitoring of tumor.
Treg cells are regulatory T cells, which are the basic ce... Detailed information